ArticleInterdisciplinary cardiovascular and thoracic surgery2025
Sleeve resection with or without parenchymal resection for proximal bronchial carcinoids: a retrospective analysis of recurrence and lymph node involvement.
Article in Interdisciplinary cardiovascular and thoracic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Endobronchial Pulmonary Typical Carcinoid Tumors in Young Adults: A Three-Case Series Highlighting Obstructive Complications and Surgical Outcomes.Cancer management and research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesRisk factors of recurrence in sleeve resection for endobronchial carcinoid tumors are well known. However, the impact of parenchymal sparing has not been studied. This study aims to determine whether associated parenchymal removal improves the oncologic outcomes.
methodsBetween 2002 and 2022, 95 patients underwent a sleeve resection for carcinoid tumors in two centers, 29 a bronchial sleeve resection (BSR) without parenchymal resection and 66 a parenchymal sleeve resection (PSR). Similar lymph node dissection was performed in both groups.
resultsThe BSR group had more proximal tumors (p < 0.001) and higher NYHA class function (p < 0.001). The PSR group had more distal (p < 0.001) and larger tumors (p = 0.04). Preoperative bronchoscopic resection did not reduce "complex" sleeve resections, postoperative complications, or tumour recurrence rates. Ninety-day mortality was 0%. Postoperative complications, occurred in 18 patients (18.9%), with three bronchial fistulae (3.2%) and no anastomotic stenoses. All BSR patients were N0, while the PSR group had higher lymph node involvement (22.7% vs 0%; p = 0.004). Mean overall and recurrence-free survival were 104.1 and 100.9 months, respectively. Ten recurrences occurred, nine in the PSR group (p = 0.27). Associated parenchymal removal did not reduce risk of recurrence (p = 0.10). Atypical carcinoids and Ki-67 ≥ 5% were linked to lower recurrence-free survival in univariable analysis. Lymph node involvement was an independent risk factor for recurrence (p = 0.002) in multivariable analysis.
conclusionsAbsence of parenchymal resection did not affect oncologic outcomes, with minimal morbidity. Lymph node involvement was an independent risk factor for recurrence highlighting the importance of lymph node dissection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.